Israel Englander Medical Devices

Millennium Management LLC

$192 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
EW Edwards Lifesciences Corp	$47.6B	$523 Million 0.27% of portfolio	6,682,000	Q2 2025 Added 93.98%
BSX Boston Scientific Corp	$147B	$498 Million 0.26% of portfolio	4,636,019	Q2 2025 Reduced 44.44%
MDT Medtronic PLC	$122B	$351 Million 0.18% of portfolio	4,022,565	Q2 2025 Added 333.35%
ALGN Align Technology Inc	$11B	$143 Million 0.07% of portfolio	753,489	Q2 2025 Reduced 15.99%
LIVN Liva Nova PLC	$2.71B	$109 Million 0.06% of portfolio	2,425,781	Q2 2025 Added 17.47%
PODD Insulet Corp	$21.5B	$73.7 Million 0.04% of portfolio	234,631	Q2 2025 Reduced 13.01%
BIO Bio Rad Laboratories, Inc.	$6.77B	$60.8 Million 0.03% of portfolio	251,848	Q2 2025 Reduced 25.06%
IRTC I Rhythm Technologies, Inc.	$4.87B	$51.8 Million 0.03% of portfolio	336,307	Q2 2025 Reduced 15.87%
ITGR Integer Holdings Corp	$3.56B	$31.6 Million 0.02% of portfolio	257,313	Q2 2025 Added 108.97%
ABT Abbott Laboratories	$229B	$23 Million 0.01% of portfolio	169,029	Q2 2025 Reduced 75.1%
DXCM Dexcom Inc	$31B	$21.9 Million 0.01% of portfolio	251,311	Q2 2025 Reduced 27.48%
STE Steris PLC	$24.4B	$19 Million 0.01% of portfolio	78,941	Q2 2025 Reduced 44.53%
TNDM Tandem Diabetes Care Inc	$713M	$18.1 Million 0.01% of portfolio	969,073	Q2 2025 Added 325.81%
INMD In Mode Ltd.	$1.18B	$17.8 Million 0.01% of portfolio	1,233,065	Q2 2025 Added 1,325.97%
PEN Penumbra Inc	$9.42B	$17.5 Million 0.01% of portfolio	68,209	Q2 2025 Reduced 54.09%
KIDS Orthopediatrics Corp	$449M	$16.8 Million 0.01% of portfolio	781,027	Q2 2025 Added 18.95%
UFPT Ufp Technologies Inc	$1.66B	$16.5 Million 0.01% of portfolio	67,666	Q2 2025 Reduced 27.84%
TMDX Trans Medics Group, Inc.	$4.17B	$15.4 Million 0.01% of portfolio	114,914	Q2 2025 New
SNN Smith & Nephew PLC	$15.8B	$12.5 Million 0.01% of portfolio	408,257	Q2 2025 Reduced 73.9%
RXST Rx Sight, Inc.	$203M	$12.4 Million 0.01% of portfolio	951,177	Q2 2025 Added 5.94%
PRCT Procept Bio Robotics Corp	$1.72B	$11 Million 0.01% of portfolio	190,292	Q2 2025 Reduced 64.95%
IART Integra Lifesciences Holdings Corp	$1.15B	$10.3 Million 0.01% of portfolio	836,814	Q2 2025 Added 99.73%
TMCI Treace Medical Concepts, Inc.	$362M	$8.92 Million 0.0% of portfolio	1,517,211	Q2 2025 Added 241.03%
OFIX Orthofix Medical Inc.	$276M	$8.82 Million 0.0% of portfolio	790,868	Q2 2025 Added 1,065.41%
IRMD Iradimed Corp	$917M	$6.67 Million 0.0% of portfolio	111,628	Q2 2025 Added 59.13%
SIBN Si Bone, Inc.	$521M	$6.36 Million 0.0% of portfolio	337,768	Q2 2025 Added 47.14%
ATEC Alphatec Holdings, Inc.	$1.65B	$5.38 Million 0.0% of portfolio	484,956	Q2 2025 Added 44.75%
SRDX Surmodics Inc	$531M	$4.62 Million 0.0% of portfolio	155,618	Q2 2025 Reduced 24.64%
ZIMV Zim Vie Inc.	$494M	$4.48 Million 0.0% of portfolio	479,285	Q2 2025 Reduced 32.28%
PHG Koninklijke Philips Nv	$23.9B	$4.43 Million 0.0% of portfolio	184,926	Q2 2025 Reduced 82.1%
AORT Artivion, Inc.	$1.74B	$4.42 Million 0.0% of portfolio	142,237	Q2 2025 Reduced 11.28%
BFLY Butterfly Network, Inc.	$241M	$4.36 Million 0.0% of portfolio	2,180,584	Q2 2025 Reduced 42.38%
CERS Cerus Corp	$228M	$4.16 Million 0.0% of portfolio	2,950,761	Q2 2025 Reduced 8.43%
BRKR Bruker Corp	$4.79B	$4.12 Million 0.0% of portfolio	99,979	Q2 2025 Reduced 50.58%
BVS Bioventus Inc.	$451M	$4.01 Million 0.0% of portfolio	606,044	Q2 2025 Added 109.59%
VREX Varex Imaging Corp	$422M	$3.6 Million 0.0% of portfolio	415,519	Q2 2025 Reduced 8.87%
DCTH Delcath Systems, Inc.	$93.5M	$3.4 Million 0.0% of portfolio	249,755	Q2 2025 Reduced 40.83%
CTKB Cytek Biosciences, Inc.	$543M	$3.14 Million 0.0% of portfolio	924,772	Q2 2025 Added 86.66%
LUNG Pulmonx Corp	$59.3M	$3.02 Million 0.0% of portfolio	1,166,527	Q2 2025 Added 459.54%
AVNS Avanos Medical, Inc.	$502M	$2.66 Million 0.0% of portfolio	217,344	Q2 2025 Reduced 60.32%
ELMD Electromed, Inc.	$164M	$2.16 Million 0.0% of portfolio	98,104	Q2 2025 Reduced 49.57%
GMED Globus Medical Inc	$4.73B	$2.02 Million 0.0% of portfolio	34,233	Q2 2025 Added 150.85%
RCEL Avita Medical, Inc.	$138M	$1.95 Million 0.0% of portfolio	369,192	Q2 2025 Added 2,980.45%
CVRX Cv Rx, Inc.	$155M	$1.9 Million 0.0% of portfolio	323,158	Q2 2025 Reduced 0.69%
SYK Stryker Corp	$142B	$1.73 Million 0.0% of portfolio	4,370	Q2 2025 Reduced 84.43%
TCMD Tactile Systems Technology Inc	$253M	$1.62 Million 0.0% of portfolio	160,053	Q2 2025 Reduced 10.3%
ANIK Anika Therapeutics, Inc.	$127M	$1.41 Million 0.0% of portfolio	133,673	Q2 2025 Added 72.37%
CLPT Clear Point Neuro, Inc.	$258M	$1.19 Million 0.0% of portfolio	99,871	Q2 2025 Reduced 86.53%
AXGN Axogen, Inc.	$599M	$1.13 Million 0.0% of portfolio	104,386	Q2 2025 Added 805.42%
ZBH Zimmer Biomet Holdings, Inc.	$21.4B	$1.1 Million 0.0% of portfolio	12,109	Q2 2025 Reduced 98.21%

Shares Options

Israel Englander

Israel Englander is the founder and CEO of Millennium Management, a successful investment firm that uses technology and data-driven approaches to investing. Englander is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Israel Englander's portfolio

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account